St. Jude Daig Division Splits To Emphasize Vascular Closure, AF Devices

Newly appointed president of St. Jude Medical's cardiology division Paul Buckman will work to retain AngioSeal's number-one position in the U.S. vascular closure device market as newcomer Abbott Labs tries to gain ground